Patent · US Active

Polymeric, degradable drug-eluting stents and coatings

US8961591B2 · kind B2 · utility

0Cited by
24References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 17, 2009
Grant dateFeb 24, 2015
Priority date
Expiry dateJul 28, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2300/606
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Absorbable stents and absorbable stent coatings have been developed with improved properties. These devices preferably comprise biocompatible copolymers or homopolymers of 4-hydroxybutyrate, and optionally poly-L-lactic acid and other absorbable polymers and additives. Compositions of these materials can be used to make absorbable stents that provide advantageous radial strengths, resistance to recoil and creep, can be plastically expanded on a balloon catheter, and can be deployed rapidly in vivo. Stent coatings derived from these materials provide biocompatible, uniform coatings that are ductile, and can be expanded without the coating cracking and/or delarmnating and can be used as a coating matrix for drug incorporation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.